Magnendo
Newton, US · Founded 2024 · Delaware corporation · 1 known investors
Magnendo develops a magnetically steerable soft-robotic guidewire system for neurovascular endovascular procedures, enabling physicians to access hard-to-reach targets in the brain's blood vessels for stroke and aneurysm treatment. The system is designed to reduce procedural time, complications, and costs while improving patient outcomes.
Founders & leadership
Magnendo was founded in 2024 by Yoonho Kim.
YK

Yoonho KimPresident, CEO and Secretary
JA
Jeffrey ArnoldChairman and Treasurer
AP
Aman PatelChief Medical Officer
MR
Meir RosenbergChief Development Officer
XZ

Xuanhe ZhaoNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$20.3M disclosed across 2 rounds · 2024–2026
▶$18MraisedJul 2026 · 10 investors · BiotechnologyRule 506(b)
▶$18MraisedJul 2026 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Yoonho KimExecutive Officer, Director
- Aman PatelDirector
- Jeffrey ArnoldDirector
- Xuanhe ZhaoDirector
- Offering amount
- $18M
- Amount sold
- $18M
- First sale
- Jul 2026
- Incorporated
- Corporation, Delaware, 2024
- Federal exemptions
- 06b
▶$2.3MraisedOct 2024 · 37 investors · Other TechnologyRule 506(b)
▶$2.3MraisedOct 2024 · 37 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Yoonho KimExecutive Officer, Director
- Xuanhe ZhaoDirector
- Jeffrey ArnoldExecutive Officer, Director
- Aman PatelExecutive Officer, Director
- Meir RosenbergExecutive Officer
- Offering amount
- $3.5M
- Amount sold
- $2.3M
- Proceeds to insiders
- $465K
- First sale
- Jun 2024
- Incorporated
- Corporation, Delaware, 2024
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlapMendaera4 shared keywordsMendaera builds robotic technology, including its Focalist System for robotic-guided access and procedures such as transplant biopsy, to help healthcare providers perform reproducible clinical procedures. The company serves clinicians and healthcare providers in the medical device and surgical robotics field.
Intuitive3 shared keywordsIntuitive develops robotic-assisted surgical systems, including the da Vinci systems for minimally invasive surgery and the Ion system for bronchoscopy. Its products are medical devices used by surgeons and physicians in healthcare settings.
Companies competing with Magnendo for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Magnendo do?
- Magnendo develops a magnetically steerable soft-robotic guidewire system for neurovascular endovascular procedures, enabling physicians to access hard-to-reach targets in the brain's blood vessels for stroke and aneurysm treatment. The system is designed to reduce procedural time, complications, and costs while improving patient outcomes.
- Who founded Magnendo?
- Magnendo was founded by Yoonho Kim in 2024.
- Who are Magnendo's investors?
- Magnendo's investors include Kakao Ventures.
- How much funding has Magnendo raised?
- Magnendo has disclosed $20.3M raised across 2 rounds.
- Where is Magnendo headquartered?
- Magnendo is headquartered in Newton, US.

